Troxacitabine in Treating Patients With Chronic Myelogenous Leukemia

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of troxacitabine in treating patients who have blast phase chronic myelogenous leukemia.

Timeline

Start

2000-12-11

Primary completion

2002-03-27

Completion

2002-03-27

Drugs

Indications